Arcturus Therapeutics Holdings, Inc. (ARCT)
7.125
-0.18
(-2.40%)
USD |
NASDAQ |
Jun 08, 16:00
7.125
0.00 (0.00%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Shareholders Equity (Quarterly) : 191.36M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Ionis Pharmaceuticals, Inc. | 491.41M |
| Oncotelic Therapeutics, Inc. | 263.29M |
| Enanta Pharmaceuticals, Inc. | 116.59M |
| Veracyte, Inc. | 1.344B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 245.41M |
| Total Liabilities (Quarterly) | 54.05M |
| Debt to Equity Ratio | 0.1253 |
| Current Ratio | 6.310 |
| Net Debt Paydown Yield | 0.42% |